ABBV-838
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-838, covering 2017-06-05 to 2017-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment [Phase 1]